FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Surgery

• Publication date

  1991-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 1713358PMCID PMC2956606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PREVENTION OF GRAFT‐VERSUS‐HOST DISEASE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION IN RATS USING FK506

  1991cited by this paper
• Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.

  1991cited by this paper
• When is it time to get married? Or when should the assay user and the assay developer collaborate?

  1991cited by this paper
• Liver, Kidney, and Thoracic Organ Transplantation Under FK 506

  1990cited by this paper
• SUPPRESSION OF ALLOGRAFT REJECTION WITH FK506: I. PROLONGED CARDIAC AND LIVER SURVIVAL IN RATS FOLLOWING SHORT‐COURSE THERAPY

  1990cited by this paper
• Management of acute graft-versus-host disease.

  1990cited by this paper
• FK 506 for liver, kidney, and pancreas transplantation.

  1989cited by this paper
• A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase

  1989cited by this paper
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

  1989cited by this paper
• FK 506 for human liver, kidney, and pancreas transplantation

  1989cited by this paper
• The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

  1989cited by this paper
• Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

  1988cited by this paper
• Orthotopic liver transplantation in dogs receiving FK-506.

  1987cited by this paper
• The major histocompatibility complex of the rat.

  1987cited by this paper
• STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG‐TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATS

  1987cited by this paper
• STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOG

  1987cited by this paper
• FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

  1987cited by this paper
• Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.

  1986cited by this paper
• Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease.

  1984cited by this paper
• Allogeneic Bone‐Marrow Transplantation

  1983cited by this paper
• Effect of cyclosporin A on the anti-leukaemia action associated with graft-versus-host disease.

  1983cited by this paper
• Major histocompatibility complex of the rat

  1982cited by this paper
• Sequential morphology of graft-versus-host disease in the rat radiation chimera

  1982cited by this paper
• Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids

  1981cited by this paper
• Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal.

  1981cited by this paper
• Use of cyclosporin A in allogeneic bone marrow transplantation in the rat

  1979cited by this paper
• Cyclosporin A for the treatment of graft-versus-host disease in man.

  1978cited by this paper
• Bone-marrow transplantation (second of two parts).

  1975cited by this paper
• Treatment of established human graft-versus-host disease by antithymocyte globulin.

  1974cited by this paper

• Mouse models in bone marrow transplantation and adoptive cellular therapy.

  2013cites this paper
• Cyclosporin

  2012cites this paper
• transplantation versus-host disease after matched unrelated donor marrow Tacrolimus and minidose methotrexate for prevention of acute graft-

  2011cites this paper
• single-center study disease after marrow transplantation from HLA-matched siblings: a methylprednisolone for the prevention of acute graft-versus-host Tacrolimus (FK506) alone or in combination with methotrexate or

  2011cites this paper
• FK 506 ( Tacrolimus ) Monotherapy for Prevention of Graft-Versus-Host Disease After Histocompatible Sibling Allogeneic Bone Marrow Transplantation

  2002cites this paper
• IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection.

  2001cites this paper
• Differences between cyclosporin A and tacrolimus in organ transplantation.

  1999cites this paper
• Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival

  1999cites this paper
• Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat.

  1999cites this paper
• Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.

  1998cites this paper
• Allogeneic Hepatocyte Transplantation Using FK 506

  1997cites this paper
• Inhibition of murine chronic graft-versus-host disease by the chloroform extract of Tripterygium wilfordii Hook f.

  1997cites this paper
• Clinical Aspects and Immunosuppression

  1997cites this paper
• Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from The Eastern Cooperative Oncology Group (ECOG)

  1997cites this paper
• Tacrolimus and Minidose Methotrexate for Prevention of Acute Graft- Versus-Host Disease After Matched Unrelated Donor Marrow Transplantation

  1996cites this paper
• FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.

  1996cites this paper
• Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.

  1996cites this paper
• Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.

  1996cites this paper
• 7 – Role of Nitric Oxide in Allograft Rejection

  1996cites this paper
• Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.

  1995cites this paper
• New and experimental therapies for treating graft-versus-host disease.

  1995cites this paper
• Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.

  1994cites this paper
• The latest advances in liver transplantation at the pittsburgh transplantation institute: evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance.

  1994cites this paper
• Recommended Guidelines for the Management of Autologous and Allogeneic Bone Marrow Transplantation: A Report from the Eastern Cooperative Oncology Group (ECOG)

  1994cites this paper
• Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.

  1994cites this paper
• FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.

  1994cites this paper
• GRAFT‐VERSUS‐HOST DISEASE AFTER BROWN NORWAY‐TO‐LEWIS AND LEWIS‐TO‐BROWN NORWAY RAT INTESTINAL TRANSPLANTATION UNDER FK506

  1993cites this paper
• CLINICAL COURSE, MORPHOLOGY, AND TREATMENT OF CHRONICALLY REJECTING SMALL BOWEL ALLOGRAFTS

  1993cites this paper
• Prevention and treatment of acute GvHD--new modalities.

  1993cites this paper
• Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function.

  1993cites this paper
• Graft-versus-host disease following liver transplantation.

  1992cites this paper
• Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.

  1992cites this paper
• Advances in transplantation

  1992cites this paper
• Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat.

  1992cites this paper
• Management of intestinal transplantation in humans.

  1992cites this paper
• The many faces of multivisceral transplantation.

  1991cites this paper
• PREVENTION OF GRAFT‐VERSUS‐HOST DISEASE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION IN RATS USING FK506

  1991cites this paper
• Overview of FK506 in transplantation.

  1990cites this paper